Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.280
-0.020 (-0.61%)
Sep 2, 2026, 5:29 PM CET

Sprint Bioscience AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
34815511012122191
Market Cap Growth
478.95%40.43%-8.82%449.78%-88.47%17.26%
Enterprise Value
2551447966-5105
Last Close Price
3.301.471.561.710.544.72

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
4.591.69----
Forward PE
13.555.881.762.4811.062.01
PS Ratio
2.510.931.672.34265.475.45
PB Ratio
3.871.3011.914.360.782.71
P/TBV Ratio
3.871.3011.914.360.782.71
P/FCF Ratio
5.091.86-5.93--
P/OCF Ratio
5.051.86-5.30--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.830.861.191.28-3.01
EV/EBITDA Ratio
3.201.46----
EV/EBIT Ratio
3.251.48----
EV/FCF Ratio
3.721.73-3.24--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.03-1.06-2.70-1.80-1.05-1.00
Net Debt / EBITDA Ratio
-1.17-1.281.4157.000.492.84
Net Debt / FCF Ratio
-1.36-1.521.02-2.450.501.65
Asset Turnover
1.951.871.271.040.000.62
Quick Ratio
7.097.601.141.673.788.74
Current Ratio
7.097.601.141.673.788.74
Return on Equity (ROE)
144.94%142.84%-98.67%-1.57%-122.00%-63.02%
Return on Assets (ROA)
68.66%68.23%-22.46%-1.66%-65.01%-28.29%
Return on Capital Employed (ROCE)
87.10%81.80%-202.40%-4.80%-215.00%-36.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
21.73%59.14%-16.55%-0.36%-273.08%-13.13%
FCF Yield
19.66%53.79%-22.32%16.85%-268.02%-22.41%
Buyback Yield / Dilution
-37.46%-32.63%-0.01%-65.98%-45.85%-71.85%